Autologous (patients own) cells taken from bone marrow
“Prium Non Nocere“, which means “Not to harm”, as the treatment of any disease should not be more harmful than when leaving it untreated.
No profit objective
Unmanipulated Mesenchymal stem cells
Presence of platelet and growth factor rich plasma makes it more effective.
Point of care-so no risk of contamination
Cells maximum in no per ml compared to any enrichment tech available
Polyclonal in nature
No risk of rejection
Least side effects
Syringe containg stem cells can be made avaialble for cross verification
Route of administration individualised according to the disorder
Scientificaly monitored by a strict protocol.
Ficoll* not used
As per the ICMR guidelines, these are done only as an experimental study